Unraveling adenosine and AMP induced dyspnea sensation in asthma

C. Cox (Groningen, Netherlands), I. Boudewijn (Groningen, Netherlands), S. Vroegop (Groningen, Netherlands), S. Schokker (Groningen, Netherlands), A. Lexmond (Groningen, Netherlands), H. Frijlink (Groningen, Netherlands), P. Hagedoorn (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), M. Farenhorst (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands)

Source: International Congress 2018 – Tests and trends in asthma
Session: Tests and trends in asthma
Session type: Thematic Poster
Number: 3961
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Cox (Groningen, Netherlands), I. Boudewijn (Groningen, Netherlands), S. Vroegop (Groningen, Netherlands), S. Schokker (Groningen, Netherlands), A. Lexmond (Groningen, Netherlands), H. Frijlink (Groningen, Netherlands), P. Hagedoorn (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), M. Farenhorst (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands). Unraveling adenosine and AMP induced dyspnea sensation in asthma. 3961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tussive challenge with ATP and AMP: does it reveal cough hypersensitivity?
Source: Eur Respir J , 49 (2) 1601452; DOI: 10.1183/13993003.01452-2016
Year: 2017



Effects of salbutamol on gas exchange abnormalities and sputum neutrophilia induced by adenosine 5‘-monophosphate (AMP) in mild asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 669s
Year: 2006

The adenosine A2A-Receptor is not involved in adenosine induced bronchoconstriction in asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 103s
Year: 2003

The perception of breathlessness during bronchoconstriction induced by mannitol in COPD
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction
Source: Eur Respir J 2001; 18: Suppl. 33, 46s
Year: 2001

Cellular and gas exchange responses to adenosine 5‘-monophosphate (AMP) challenge in mild asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004

Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis
Source: Eur Respir J 2001; 17: 64-70
Year: 2001



Blunted sensation of dyspnoea and near fatal asthma
Source: Eur Respir J 2004; 24: 197-199
Year: 2004


Characterization of methacholine-induced cough and its influence on cough reflex sensitivity and airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 591s
Year: 2005

Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine
Source: Eur Respir J 2002; 19: 611-616
Year: 2002



Changes in the pattern of breathing and dyspnoea sensation during methacholine-induced bronchoconstriction in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 86s
Year: 2001

Peculiarities of dyspnea sensations in asthma patients
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010


Chronic cough: ATP, afferent pathways and hypersensitivity
Source: Eur Respir J, 54 (1) 1900889; 10.1183/13993003.00889-2019
Year: 2019



Effect of adenosine 5´-triphosphate (ATP) challenge vs. adenosine 5´-monophosphate (AMP) on the threshold of capsaicin-induced cough in healthy non-smokers, current smokers and patients with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 708s
Year: 2004

Association between atopic status and airway reactivity to methacholine and adenosine monophosphate
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


ATP and cough reflex hypersensitivity: a confusion of goals?
Source: Eur Respir J, 50 (1) 1700802; 10.1183/13993003.00802-2017
Year: 2017



ATP and cough reflex hypersensitivity: a confusion of goals?
Source: Eur Respir J, 50 (1) 1700579; 10.1183/13993003.00579-2017
Year: 2017



An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP)
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

The bronchoprotective effects of levocetirizine on adenosine monophosphate challenge in patients with atopic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 220s
Year: 2004